Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - clofaziminum - kapseln - clofaziminum 50 mg, rapae oleum raffinatum, lecithinum, sojae oleum partim hydrogenatum 4.666 mg, sojae oleum hydrogenatum 1.166 mg, cera flava, propylenglycolum, e 321, acidum citricum, kapselhülle: gelatina, glycerolum (85 per centum), e 172 (rubrum), e 172 (nigrum), e 215 230 µg, ethylvanillinum, propylis parahydroxybenzoas natricus 110 µg, 4-methoxyacetophenonum, aqua purificata, pro capsula. - lepra - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - clofaziminum - kapseln - clofaziminum 100 mg, rapae oleum raffinatum, lecithinum, sojae oleum partim hydrogenatum 9.333 mg, sojae oleum hydrogenatum 2.333 mg, cera flava, propylenglycolum, e 321, acidum citricum, kapselhülle: gelatina, glycerolum (85 per centum), e 172 (rubrum), e 172 (nigrum), e 215 550 µg, ethylvanillinum, propylis parahydroxybenzoas natricus 280 µg, 4-methoxyacetophenonum, aqua purificata, drucktinte: lacca, e 171, propylenglycolum, pro capsula. - lepra - synthetika